American Journal of Nephrology · 2000 · 79 citations · 20 references
MedicineInfectious DiseasesMicrobiologyDialysisHemodialysisVirologyHand HygieneInfectious Disease Molecular TestingTransfusion-transmitted InfectionsViral HepatitisBlood Transfusion TransmissionDialysis-related InfectionsHealthcare Worker TransmissionHepatitis C Virus TransmissionNosocomial Transmission AnalysisNosocomial Transmission InvestigationViral Contamination AssessmentViral Hepatitis Transmission
BACKGROUND: Hepatitis C virus (HCV) is a major cause of hepatitis in hemodialysis (HD) patients. Routes other than blood transfusion play a role in the spread of HCV in HD patients. Molecular studies of HCV implicate nosocomial transmission of the virus in HD units. We conducted a clinicovirological study in our HD unit to investigate if the hands of dialysis personnel could represent a mode of transmission of HCV among HD patients. METHODS: One liter of sterile water was used for each handwashing of dialysis personnel. The washing was collected in a sterile container and tested for HCV-RNA by polymerase chain reaction (PCR) within 3 h of collection. Eighty handwashings from nurses dialyzing HCV-positive patients (groupe A) and 100 handwashing from nurses dialyzing HCV-negative patients (group B) were tested for HCV-RNA. As a control, 60 handwashings were collected from the dialysis personnel before entering the dialysis unit (group C) and tested for HCV-RNA. RESULTS: HCV-RNA was positive in 19 (23.75%) of samples of group A, in 8 (8%) of samples of group B (p < 0.003) and in 2 (3.3%) of samples of group C (p < 0. 35). These two positive samples of group C were from nurses who had dialyzed HCV-negative patients. CONCLUSION: These results indicate the presence of HCV-RNA on the hands of some dialysis personnel in our HD unit, in spite fo adherence to the standard precautions. The hands of dialysis personnel are therefore a potential mode for facilitating transmission of HCV between HD patients.
20
Avoiding false positives with PCR
Shirley Kwok, Russell Higuchi · Nature · 1989 · 3.5K citations
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
L. Viladomiu, Antonio González, M Roget et al. · The Lancet · 1989 · 900 citations
Side effects of high-dose interferon therapy for chronic hepatitis C
T Okanoue, Shinichi Sakamoto, Yoshito Itoh et al. · Journal of Hepatology · 1996 · 463 citations
Antibody to hepatitis C virus increases with time on hemodialysis.
Hardy Nm, Stephen Sandroni, Sarah Mann Danielson et al. · PubMed · 1992 · 153 citations